Related Experiment Videos
Blood coagulation factors as inflammatory mediators.
Saskia H H F Schoenmakers1, Pieter H Reitsma, C Arnold Spek
1Laboratory for Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Blood Cells, Molecules & Diseases
|December 21, 2004
Summary
Coagulation factors like tissue factor (TF) and thrombin have roles beyond blood clotting, influencing inflammation and disease. Understanding their molecular mechanisms is key to new therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathophysiology
Background:
- The classic theory of blood coagulation has evolved significantly since Hippocrates.
- Discovery of new coagulation factors expanded the understanding of the coagulation cascade.
- Recent research reveals coagulation factors possess functions beyond hemostasis.
Purpose of the Study:
- To review the coagulation-independent roles of key coagulation factors.
- To explore the involvement of coagulation factors in inflammation.
- To highlight the challenges in understanding their pleiotropic effects.
Main Methods:
- Literature review of recent scientific findings.
- Analysis of studies on coagulation factors like tissue factor (TF), FVII, FX, and thrombin.
- Focus on molecular mechanisms underlying non-hemostatic functions.
Main Results:
- Coagulation factors are implicated in inflammation, vascular development, angiogenesis, and tumorigenesis.
- Tissue factor (TF), FVII, FX, and thrombin exhibit significant pleiotropic effects.
- The molecular pathways for these effects are still under investigation.
Conclusions:
- Coagulation factors play critical roles in diverse physiological and pathological processes.
- Further research is needed to elucidate the molecular mechanisms of their inflammation-inducing properties.
- Understanding these mechanisms could lead to novel therapeutic targets.